Join to view full profile
5841 S. MARYLANDM/C 2115Chicago, IL 60637
Phone+1 773-702-8412
Fax+1 773-834-0188
Dr. Riedell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Peter Riedell, MD, is an oncology specialist located in Chicago, IL, with a subspecialty in hematologic oncology. He completed a fellowship in hematology and medical oncology and a residency in internal medicine at the Washington University/B-JH/SLCH Consortium. Dr. Riedell's expertise includes non-Hodgkin lymphoma, Hodgkin's lymphoma, lymphoma, stem cell transplantation, and chimeric antigen receptor (CAR) T-cell therapy. His research has been published in journals such as Blood Advances and Transplantation and Cellular Therapy. He has been involved in several clinical trials focused on treatments for lymphoma, specifically exploring the safety and efficacy of therapies like Axicabtagene Ciloleucel and Tisagenlecleucel.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2013 - 2016- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2010 - 2013
University of Tennessee Health Science Center College of MedicineClass of 2010
Certifications & Licensure
IL State Medical License 2016 - 2029
MO State Medical License 2012 - 2017
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas Start of enrollment: 2015 Feb 04
- Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2016 Oct 12
- Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission Start of enrollment: 2017 Nov 27
Publications & Presentations
PubMed
- Longitudinal patient-reported outcomes and quality-of-life trajectories over 2 years in CAR-T therapy recipients.Vincenzo J Pizzuti, Angela Dunn, Kathryn Colborn, Mckenzie Schubat, Thomas Althaus
Blood Neoplasia. 2026-11-01 - Outcomes and Safety of CAR-T Cell Therapy in B-NHL Patients With Reduced Left Ventricular Ejection Fraction.Alexandra E Rojek, Jia Guo, Justin Kline, Satyajit Kosuri, Michael R Bishop
Transplantation and Cellular Therapy. 2026-10-01 - Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.Karan L Chohan, Lei Feng, Hunter Cochran, Maya Rosenberg, Leidy Isenalumhe
British Journal of Haematology. 2026-09-27
Abstracts/Posters
- Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive LymphomasPeter A. Riedell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Rapid Undetectable MRD (uMRD) Responses in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Lisoc...Peter A. Riedell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Axicabtagene Ciloleucel in Combination with Either Rituximab or Lenalidomide in Patients...Peter A. Riedell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Axi-Cel vs Tisa-Cel in the Real World: Patterns of Use, Efficacy, and Safety in B-cell LymphomaApril 22nd, 2020
Experts Break down Latest CAR T-cell Advances in LymphomaJanuary 22nd, 2020
Triplet Notches Survival Win in Heavily Pretreated DLBCLJune 3rd, 2024
Professional Memberships
- Member
- Member
- American Society of Transplantation and Cellular Therapy - ASTCTMember
External Links
- Jonas Center Cellular Therapy Symposiumhttps://www.jonascentersymposium.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: